trans-1,2-dihydro-1,2-naphthalenediol has been researched along with pci 32765 in 5 studies
Studies (trans-1,2-dihydro-1,2-naphthalenediol) | Trials (trans-1,2-dihydro-1,2-naphthalenediol) | Recent Studies (post-2010) (trans-1,2-dihydro-1,2-naphthalenediol) | Studies (pci 32765) | Trials (pci 32765) | Recent Studies (post-2010) (pci 32765) |
---|---|---|---|---|---|
29 | 0 | 15 | 1,926 | 243 | 1,895 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 3 (60.00) | 2.80 |
Authors | Studies |
---|---|
Beijnen, JH; Rood, JJM; Schellens, JHM; Schinkel, AH; Sparidans, RW; van Hoppe, S | 1 |
Beijnen, JH; Dormans, PJA; Rood, JJM; Schellens, JHM; Sparidans, RW; van Haren, MJ | 1 |
Allal, B; Chatelut, E; De Barros, S; Despas, F; Dupré, L; Gallais, F; Obéric, L; Protin, C; Quillet-Mary, A; Thomas, F; White-Koning, M; Ysebaert, L | 1 |
Balogh, A; Bödör, C; Karvaly, GB; Köllő, Z; Vásárhelyi, B; Vincze, I | 1 |
Chen, XL; Guo, YJ; Ma, H; Qian, ZY; Shen, H; Sun, LN; Wang, YQ; Zhao, Y | 1 |
5 other study(ies) available for trans-1,2-dihydro-1,2-naphthalenediol and pci 32765
Article | Year |
---|---|
Liquid chromatography-tandem mass spectrometric assay for the simultaneous determination of the irreversible BTK inhibitor ibrutinib and its dihydrodiol-metabolite in plasma and its application in mouse pharmacokinetic studies.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Animals; Chromatography, Liquid; Humans; Mice; Naphthalenes; Pilot Projects; Piperidines; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Tandem Mass Spectrometry | 2016 |
Bioanalysis of ibrutinib, and its dihydrodiol- and glutathione cycle metabolites by liquid chromatography-tandem mass spectrometry.
Topics: Adenine; Aged; Chromatography, Liquid; Drug Stability; Glutathione; Humans; Linear Models; Male; Naphthalenes; Piperidines; Pyrazoles; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2018 |
Population Pharmacokinetics of Ibrutinib and Its Dihydrodiol Metabolite in Patients with Lymphoid Malignancies.
Topics: Adenine; Adult; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Naphthalenes; Piperidines | 2020 |
A High-Throughput Clinical Laboratory Methodology for the Therapeutic Monitoring of Ibrutinib and Dihydrodiol Ibrutinib.
Topics: Adenine; Humans; Laboratories, Clinical; Leukemia, Lymphocytic, Chronic, B-Cell; Naphthalenes; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines | 2022 |
Simultaneous Determination of Orelabrutinib, Zanubrutinib, Ibrutinib and Its Active Metabolite in Human Plasma Using LC-MS/MS.
Topics: Acetonitriles; Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Protein Kinase Inhibitors; Reproducibility of Results; Tandem Mass Spectrometry | 2023 |